期刊
MEDCHEMCOMM
卷 3, 期 8, 页码 926-931出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c2md20008b
关键词
-
资金
- NIH [CA 77248]
- National Cancer Institute [F32 CA137944]
Inhibitors of glucose-6-phosphate translocase (G6P T1) control aberrant glucose levels and show promise as anticancer and anti-diabetic agents. This mini-review provides a concise overview of natural product and natural product analogs that inhibit G6P T1. The discovery and development of these inhibitors, as well as their efficacy in cell-based assays and in vivo, are discussed. Finally, we acknowledge the need for improved G6P T1 inhibitors and the potential to harness the programmable chemistry of microorganisms to meet this need.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据